39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Malaria remains a significant global health challenge, with millions of people affected and thousands of deaths each year. New Horizons in Antimalarial Drug Discovery: Identifying and Validating Drug Targets against FP3 offers a comprehensive overview of the latest developments in the search for effective antimalarial drugs. This book focuses on the identification and validation of drug targets against FP3, a critical enzyme in the survival and replication of the malaria parasite. With contributions from leading experts in the field, readers will gain valuable insights into cutting-edge…mehr

Produktbeschreibung
Malaria remains a significant global health challenge, with millions of people affected and thousands of deaths each year. New Horizons in Antimalarial Drug Discovery: Identifying and Validating Drug Targets against FP3 offers a comprehensive overview of the latest developments in the search for effective antimalarial drugs. This book focuses on the identification and validation of drug targets against FP3, a critical enzyme in the survival and replication of the malaria parasite. With contributions from leading experts in the field, readers will gain valuable insights into cutting-edge techniques and strategies for drug discovery. This book is a must-read for researchers, clinicians, and policymakers who are committed to improving global health by combating malaria.
Autorenporträt
La dott.ssa Trisha Rajguru ha conseguito il dottorato di ricerca in scienze biologiche presso l'Università di Dibrugarh nel 2023, dove si è specializzata in biochimica e la sua tesi era incentrata sullo studio dell'attività antiplasmodiale delle carbaldeidi non peptidiche sulle falcipine. La dott.ssa Rajguru ha anche conseguito un diploma di laurea. Le è stata assegnata una borsa di studio per donne scienziate dal DST, GoI.